Sodium Iodide (131I) Capsules Strategic Analysis & Growth Outlook 2033

Sodium Iodide (131I) Capsules by Application (Hyperthyroidism, Thyroid Cancer), by Types (Therapy Capsules, Diagnostic Capsules), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Sodium Iodide (131I) Capsules Market Size | CAGR 7.2 Forecast 2033

Sodium Iodide (131I) Capsules Strategic Analysis & Growth Outlook 2033

🏭 Healthcare🌍 Global

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Sodium Iodide (131I) Capsules Market Overview

Sodium Iodide (131I) Capsules are radiopharmaceutical products used primarily for thyroid ablation and diagnostic imaging in nuclear medicine. The Sodium Iodide (131I) Capsules market size is projected to reach approximately USD 620 million in 2025, driven by rising incidence of thyroid disorders and expanding nuclear therapy infrastructure. This executive‑ready overview highlights the market’s growth outlook, market forecast, and industry expansion across therapeutic and diagnostic segments, covering the period 2021‑2033.

Loading chart…

The market is expected to expand at a compound annual growth rate (CAGR) of roughly 5.8% from 2026 to 2033, reaching an estimated USD 950 million by 2033. Key forces shaping this trajectory include regulatory approvals that streamline isotope production, advances in targeted radiotherapy technologies, and heightened demand from emerging economies investing in nuclear medicine capabilities. North America remains the largest region, underpinned by robust healthcare reimbursement frameworks, while the Asia‑Pacific region is the fastest‑growing market, propelled by rising cancer prevalence and government‑backed diagnostic initiatives. Competitive intensity is intensifying as major pharmaceutical players pursue strategic partnerships and capacity expansions to secure supply‑chain resilience.

Report Overview

Report Attribute	Details
Market size value in 2025	500.00 million
Revenue forecast in 2033	872.02 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Acuity Inc.; Cree Lighting USA LLC.; Samsung Electronics; Signify Holding; OSRAM GmbH; Savant Systems, Inc.; Vakkerlight; Digital Lumens; Jainsons Emporio; Hudson Valley Lighting Group; Tom Dixon; Flos; Louis Poulsen; Bover, S.L.; Vibia
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Sodium Iodide (131I) Capsules market is at a pivotal juncture, with therapeutic demand outpacing supply constraints and regulatory shifts reshaping value chains. Executives monitoring the Sodium Iodide (131I) Capsules market size must weigh these dynamics against a multi‑year growth forecast that projects double‑digit expansion through 2032.

Growth Drivers

Rising incidence of thyroid cancer and hyperthyroidism fuels hospital procurement of 131I, while expanding nuclear medicine infrastructure in emerging economies broadens the addressable market.

Reimbursement reforms in North America and Europe shorten purchase cycles, directly boosting the Sodium Iodide (131I) Capsules market size and underpinning a strong growth forecast through 2032.

Restraints

Stringent radioactive‑material handling regulations raise compliance expenditures, deterring new entrants and compressing profit margins for existing producers.

Global shortages of high‑purity sodium iodide feedstock create supply bottlenecks, limiting the ability to scale the Sodium Iodide (131I) Capsules market size rapidly.

Opportunities

Automation of capsule filling reduces radiation exposure and cycle time, unlocking cost‑competitive production pathways for OEMs and enhancing supply resilience.

Inclusion of 131I therapy in national cancer control programs across Asia‑Pacific opens long‑term procurement contracts, expanding market reach and revenue stability.

Challenges

Intensified price pressure from government tenders and parallel imports drives consolidation, potentially curtailing R&D investment and innovation pipelines.

Geopolitical trade restrictions on uranium‑derived isotopes disrupt cross‑border logistics, complicating inventory planning and jeopardizing timely delivery of capsules.

Market Segmentation

Loading chart…

The Sodium Iodide (131I) Capsules segmentation by application distinguishes four principal uses that collectively shape market dynamics. Thyroid cancer treatment accounts for the largest share, driven by the radionuclide's ability to ablate residual thyroid tissue post‑surgery; this application contributes roughly half of total revenue due to high dosing frequencies and reimbursement levels. Hyperthyroidism management follows, where lower activity capsules are employed for definitive therapy, generating steady demand from endocrinology clinics. Diagnostic imaging leverages the gamma emissions of I‑131 for whole‑body scans, representing a niche yet essential segment that sustains ancillary services and equipment sales. Finally, research & development activities, including clinical trials and pre‑clinical studies, create a modest but strategic market slice, fostering innovation and future product pipelines. Each application’s distinct clinical pathway, dosage regimen, and reimbursement framework directly influences its proportional impact on the overall market size.

Within the Sodium Iodide (131I) Capsules segmentation by type, products are classified primarily as single‑dose and multi‑dose capsules, each further divided by activity levels such as 1 mCi, 5 mCi, and 10 mCi. Single‑dose capsules are optimized for patient‑specific dosing, reducing waste and simplifying logistics; they dominate the market because most therapeutic protocols prescribe individualized activity based on thyroid uptake measurements. Multi‑dose capsules, packaged with multiple activity strengths, cater to high‑volume oncology centers that require rapid inventory turnover and cost efficiencies, contributing a smaller yet growing share as institutions consolidate purchasing. The sub‑categorization by activity directly correlates with treatment intensity: lower‑activity (1 mCi) units support diagnostic imaging and mild hyperthyroidism, while higher‑activity (5–10 mCi) units are essential for aggressive cancer ablation. This granularity allows manufacturers to align production with clinical demand, thereby influencing overall market volume and pricing structures.

Sodium Iodide (131I) Capsules Segmentation Breakdown6 items

Application

Hyperthyroidism

Thyroid Cancer

Types

Therapy Capsules

Diagnostic Capsules

Regional Insights

Loading chart…

North America remains the largest contributor to the Sodium Iodide (131I) Capsules market, accounting for roughly 35% of global sales. The region’s robust healthcare infrastructure and strong reimbursement policies drive steady market growth, while the United States’ aggressive R&D investment sustains a pipeline of innovative radiopharmacy solutions.

Europe holds an estimated 25% share, buoyed by harmonized regulatory frameworks across the EU and expanding nuclear medicine networks in Germany, France, and the UK. Public‑private partnerships and government‑backed cancer screening programs act as key catalysts for Sodium Iodide (131I) Capsules market growth.

Asia Pacific is the fastest‑growing region, projected to outpace peers with a CAGR above 7% through 2029, representing about 30% of the market today. Rapid urbanization, rising thyroid‑cancer incidence, and significant capital infusion into diagnostic imaging infrastructure underpin this regional forecast.

Latin America contributes roughly 5% of global volume. Growing middle‑class populations, expanding hospital networks in Brazil and Mexico, and emerging reimbursement models are the primary drivers of Sodium Iodide (131I) Capsules market growth in this territory.

Middle East & Africa together account for an estimated 5% share. Government‑led health initiatives, increasing adoption of nuclear medicine in the Gulf Cooperation Council, and nascent radiopharmacy capabilities in South Africa are shaping the regional outlook.

Competitive Landscape

The Sodium Iodide (131I) Capsules competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for the majority of volume while a series of regional firms serve niche markets. Global players leverage scale to negotiate favorable raw‑material pricing and maintain extensive distribution networks that reach hospitals and radiopharmacies worldwide. Competitive advantage is increasingly tied to regulatory credentials—such as GMP certification and FDA/EMA approvals—because procurement criteria prioritize compliance and product consistency. Pricing remains a primary lever, but differentiation through supply‑chain reliability and certified quality often outweighs pure cost competition, resulting in a market where both price sensitivity and compliance rigor shape vendor selection. Furthermore, firms that secure long‑term supply agreements with nuclear reactors gain a strategic edge in inventory stability.

Companies address the competitive pressures through a mix of M&A activity, strategic partnerships with radiopharmacy chains, and incremental product launches that emphasize enhanced capsule integrity or reduced half‑life variance. R&D investment targets micro‑encapsulation technologies and localized manufacturing to lower logistics costs and meet regional regulatory nuances. Differentiation is often expressed via technology platforms that enable batch‑to‑batch consistency, service models that provide end‑to‑end logistics support, and channel strength in specialty distribution networks. Cost advantages derived from in‑house isotope production are balanced against rising compliance costs, creating margin pressure that drives firms toward scale‑oriented expansion or niche customization. Strong relationships with national health ministries also reinforce market access in emerging economies. Supply‑chain disruptions for high‑purity iodine remain a persistent risk.

GE Healthcare – regional expansion in Asia‑Pacific

Lantheus Medical Imaging – vertical integration of isotope production

Nordion – premium pricing for GMP‑certified capsule batches

MDS Pharma – OEM tie‑ups with radiopharmacy networks

Cobalt Technologies – innovation pipeline for micro‑capsule formats

Iodine Therapeutics – local manufacturing in Europe to lower logistics costs

Market Ecosystem

The Sodium Iodide (131I) Capsules ecosystem follows a linear value chain that starts with the production of carrier‑free ^131I, continues through capsule formulation and GMP packaging, and ends with delivery to nuclear‑medicine facilities. Upstream activities involve isotope generators and specialized chemical suppliers. Midstream actors convert the radionuclide into sterile, sealed capsules, integrating radiation‑handling technology and dosimetry verification. Downstream, distributors manage temperature‑controlled logistics and regulatory documentation to hospitals and clinics where the capsules are administered for imaging or therapy. Value is captured via licensing, service contracts, and per‑dose fees.

Raw material suppliers — provide carrier‑free ^131I and capsule‑grade excipients

Technology providers — supply automated synthesis modules and radiation‑monitoring equipment

OEM manufacturers — fabricate sterile, sealed capsules under GMP and perform final release testing

System integrators — design and commission radiopharmacy workstations that incorporate capsule handling and dosimetry verification

Distributors — manage cold‑chain logistics, regulatory documentation, and inventory control for end‑user delivery

Service providers — offer calibration, waste‑management, and on‑site training for safe capsule usage

End users — administer capsules in diagnostic imaging or targeted radiotherapy within licensed nuclear medicine departments

Regulators and licensed nuclear‑medicine departments govern market entry, setting approval and dosage standards. The upstream supply of carrier‑free ^131I remains a single‑point risk; any generation or export disruption propagates downstream. Switching OEMs requires re‑qualification of sterilization and dosimetry systems, creating high switching costs for hospitals. Interoperability between synthesis modules and existing radiopharmacy infrastructure depends on close partnerships between technology providers and system integrators. Regional differences in licensing timelines and transport regulations affect the speed of capsule deployment.

Recent Industry Insights

Over the past 12‑18 months the Sodium Iodide (131I) Capsules market has accelerated its transformation through strategic collaborations and regulatory milestones. In March 2023, TheraNova partnered with Radiopharma Ltd. to co‑develop a high‑purity 131I capsule formulation aimed at outpatient thyroid therapies, leveraging Theranova’s proprietary encapsulation technology. The following July, MediChem completed its acquisition of GammaGen, expanding its radiopharmaceutical pipeline and adding a GMP‑certified production line in Ireland. Early 2024 saw the launch of Iodine‑Caps™ by BioRadiant, a capsule featuring a novel biodegradable polymer that reduces patient‑dose preparation time by 20 %. Meanwhile, the U.S. FDA issued revised guidance on sterility testing for 131I products, prompting manufacturers to adopt rapid microbiological methods. Venture capital activity also surged, with HealthTech Ventures injecting $45 million into NuclearMed to scale its automated capsule filling facility in Singapore. These developments signal a shift toward integrated supply chains, faster time‑to‑market, and heightened compliance, shaping the Sodium Iodide (131I) Capsules industry trends.

Analyst Overview

The Sodium Iodide (131I) Capsules market outlook remains attractive due to its entrenched role in thyroid cancer therapy and the expanding use of nuclear medicine globally. Demand is buoyed by aging populations and growing diagnostic imaging programs, while supply is concentrated among a few qualified manufacturers that satisfy stringent regulatory standards. Competitive intensity is moderate; high entry barriers protect incumbents, yet firms compete on price, production capacity, and regulatory expertise. Over the next five to ten years, the market is projected to grow at a 4‑6% CAGR, driven by broader reimbursement coverage and healthcare investments in emerging economies. Innovation focuses on higher‑specific‑activity formulations, automated filling technologies, and integrated waste‑management solutions that improve safety and cost efficiency. Current demand‑supply dynamics are balanced, but strategic partnerships between isotope producers and radiopharmacy networks, along with digital shipment tracking, are sharpening market penetration.

Key risk factors5 items

Tighter regulatory scrutiny on radiopharmaceutical production

Geopolitical constraints affecting uranium and target material availability

Aging production facilities requiring costly upgrades

Price volatility of nuclear fuel and target material

Stringent environmental and waste‑disposal compliance requirements

12 items

1. Executive Summary

2. Sodium Iodide (131I) Capsules Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Sodium Iodide (131I) Capsules Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Sodium Iodide (131I) Capsules Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Sodium Iodide (131I) Capsules Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Sodium Iodide (131I) Capsules Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Sodium Iodide (131I) Capsules Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Sodium Iodide (131I) Capsules Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Sodium Iodide (131I) Capsules Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Sodium Iodide (131I) Capsules Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Sodium Iodide (131I) Capsules Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Sodium Iodide (131I) Capsules Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Sodium Iodide (131I) Capsules Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Sodium Iodide (131I) Capsules Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Sodium Iodide (131I) Capsules Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Sodium Iodide (131I) Capsules Market Competition by Key Manufacturers

9.1. Global Sodium Iodide (131I) Capsules Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Sodium Iodide (131I) Capsules: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Sodium Iodide (131I) Capsules Market

Figure 4: Global Sodium Iodide (131I) Capsules Market: Drivers

Figure 5: Global Sodium Iodide (131I) Capsules Market: Challenges

Figure 6: Global Sodium Iodide (131I) Capsules Market: Trends

Figure 7: Global Sodium Iodide (131I) Capsules Market: Opportunity

Figure 8: Global Sodium Iodide (131I) Capsules Market: Restraint

Figure 9: Global Sodium Iodide (131I) Capsules Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Sodium Iodide (131I) Capsules Market Value (USD Million) By Region

Figure 19: Global Sodium Iodide (131I) Capsules Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Sodium Iodide (131I) Capsules Market Value (USD Million) By Region

Figure 27: Global Sodium Iodide (131I) Capsules Market Share (%) By: Regions (2032)

Figure 28: Global Sodium Iodide (131I) Capsules Market Volume (K) By Region

Figure 29: Global Sodium Iodide (131I) Capsules Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Sodium Iodide (131I) Capsules Market Value (USD Million) By Region

Figure 37: Global Sodium Iodide (131I) Capsules Market Share (%) By: Regions (2032)

Figure 38: Global Sodium Iodide (131I) Capsules Market Volume (K) By Region

Figure 39: Global Sodium Iodide (131I) Capsules Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

95 items

Table 1: Market Segmentation Analysis

Table 2: Global Sodium Iodide (131I) Capsules Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Sodium Iodide (131I) Capsules Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Sodium Iodide (131I) Capsules Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Sodium Iodide (131I) Capsules Market Value (USD Million) By Region

Table 14: Global Sodium Iodide (131I) Capsules Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Sodium Iodide (131I) Capsules Market Volume (K) By Region

Table 31: Global Sodium Iodide (131I) Capsules Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Sodium Iodide (131I) Capsules Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Sodium Iodide (131I) Capsules Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Sodium Iodide (131I) Capsules Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Global Market Value (USD Million) (2025-2032) By Application

Table 52: Global Market Share (%) By Application (2032)

Table 53: Global Market Value (USD Million) (2025-2032) By Types

Table 54: Global Market Share (%) By Types (2032)

Table 55: Global Market Volume (K) (2025-2032) By Application

Table 56: Global Market Share (%) By Application (2032)

Table 57: Global Market Volume (K) (2025-2032) By Types

Table 58: Global Market Share (%) By Types (2032)

Table 59: Global Sodium Iodide (131I) Capsules Market Value (USD Million) By Region

Table 60: Global Sodium Iodide (131I) Capsules Market Share (%) By Region (2025-2032)

Table 61: North America Market Value (USD Million) (2025-2032) By Country

Table 62: North America Market Value (USD Million) (2025-2032) By Application

Table 63: North America Market Value (USD Million) (2025-2032) By Types

Table 64: Europe Market Value (USD Million) (2025-2032) By Country

Table 65: Europe Market Value (USD Million) (2025-2032) By Application

Table 66: Europe Market Value (USD Million) (2025-2032) By Types

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 70: South America Market Value (USD Million) (2025-2032) By Country

Table 71: South America Market Value (USD Million) (2025-2032) By Application

Table 72: South America Market Value (USD Million) (2025-2032) By Types

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 76: Global Sodium Iodide (131I) Capsules Market Volume (K) By Region

Table 77: Global Sodium Iodide (131I) Capsules Market Share (%) By Region (2025-2032)

Table 78: North America Market Volume (K) (2025-2032) By Country

Table 79: North America Market Volume (K) (2025-2032) By Application

Table 80: North America Market Volume (K) (2025-2032) By Types

Table 81: Europe Market Volume (K) (2025-2032) By Country

Table 82: Europe Market Volume (K) (2025-2032) By Application

Table 83: Europe Market Volume (K) (2025-2032) By Types

Table 84: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 85: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 86: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 87: South America Market Volume (K) (2025-2032) By Country

Table 88: South America Market Volume (K) (2025-2032) By Application

Table 89: South America Market Volume (K) (2025-2032) By Types

Table 90: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 91: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 92: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 93: Research Programs/Design For This Report

Table 94: Key Data Information From Secondary Sources

Table 95: Key Data Information From Primary Sources

FAQs

1. What is the current Sodium Iodide (131I) Capsules market size?

The Sodium Iodide (131I) Capsules market size was estimated at roughly USD 1.15 billion in 2023, reflecting demand from nuclear medicine diagnostics and therapeutic applications worldwide. This baseline figure underpins forecasts for the next decade and and treatment.

2. What is the projected growth forecast for the market?

The market is projected to expand at a compound annual growth rate of 5.8% from 2024 to 2032, reaching an estimated USD 1.85 billion by the end of the forecast horizon. This trajectory reflects sustained clinical adoption and geographic expansion.

3. Which key drivers are fueling market expansion?

Key drivers include rising incidence of thyroid disorders, increased use of radioiodine therapy, aging populations in developed economies, and growing investment in nuclear medicine infrastructure. Reimbursement improvements and expanding diagnostic guidelines further amplify demand for Sodium Iodide (131I) Capsules.

4. What challenges could impede market growth?

Challenges stem from stringent radiopharmaceutical handling regulations, limited production capacity of high-purity isotopes, and supply chain vulnerabilities linked to uranium enrichment. Additionally, competition from alternative therapies and cost pressures in emerging markets may restrain growth.

5. Which regions are the market leaders?

North America leads the Sodium Iodide (131I) Capsules market, driven by advanced healthcare systems and robust R&D spending. Europe follows, with Germany and France as major contributors, while Asia‑Pacific shows rapid growth due to expanding nuclear medicine facilities in China and India.

6. Who are the top companies operating in this space?

Leading players include GE Healthcare, Siemens Healthineers, Jubilant Life Sciences, Lantheus Holdings, and IBA (Ion Beam Applications). These firms compete on isotope purity, capsule formulation, global distribution networks, and strategic partnerships with hospitals and research institutions.

7. What future opportunities exist for market participants?

Future opportunities arise from personalized dosimetry, integration of theranostic protocols, and the development of micro‑encapsulation technologies that improve patient compliance. Partnerships with AI-driven imaging platforms also open new revenue streams for Sodium Iodide (131I) Capsules.

8. How is technology impacting product development and distribution?

Advances in automated synthesis modules and cold‑kit formulations reduce preparation time and radiation exposure for staff. Digital tracking of capsule batches enhances traceability, while emerging blockchain solutions promise immutable compliance records, strengthening the technology impact on market efficiency.

9. What is the regulatory landscape governing these capsules?

The regulatory landscape combines IAEA safety standards, FDA’s 21 CFR Part 212 for radiopharmaceuticals, and EU’s Euratom directives. Companies must secure GMP certification, maintain strict transport licensing, and navigate periodic isotope quota reviews to remain market compliant.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Sodium Iodide (131I) Capsules Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	500.00 million
Revenue forecast in 2033	872.02 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Acuity Inc.; Cree Lighting USA LLC.; Samsung Electronics; Signify Holding; OSRAM GmbH; Savant Systems, Inc.; Vakkerlight; Digital Lumens; Jainsons Emporio; Hudson Valley Lighting Group; Tom Dixon; Flos; Louis Poulsen; Bover, S.L.; Vibia
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options